🔎 Trials Near Me

Akèy › Limfòm selil B › North Carolina › Charlotte

Etid klinik pou Limfòm selil B nan Charlotte, NC

7 etid pou Limfòm selil B ap chèche patisipan nan sit nan ak bò kote Charlotte (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)

Ap rekriteFaz 3
  • Atrium Health Levine Cancer Institute (Lci), Charlotte
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT06742996

Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

Ap rekriteFaz 2
  • Research Site, Charlotte
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06526793

A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies

Ap rekriteFaz 1/2
  • Research Site, Charlotte
  • Research Site, Charlotte
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06564038

A Study of ARC-02 in B-cell NHL

Ap rekriteFaz 1
  • Levine Cancer Institute, Charlotte
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT07691606

Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

Ap rekriteFaz 1
  • Levine Cancer Institute, Atrium Health, Charlotte
Laj 18 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT06792734

BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL

Ap rekriteFaz 1
  • Atrium Health Levine Cancer Institute - Morehead, Charlotte
Laj 18 ak plis · Tout sèks · Mizajou Nov 20, 2025 · NCT05370430

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Carolina-Levine Children's Hospital, Charlotte
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Limfòm selil B nan lòt vil

Lòt etid nan Charlotte

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.